Skip to main content
Erschienen in: European Archives of Oto-Rhino-Laryngology 12/2018

16.10.2018 | Short Communication

The 8th edition AJCC/UICC TNM staging for p16-positive oropharyngeal carcinoma: is there space for improvement?

verfasst von: Shachi Jenny Sharma, Steffen Wagner, Henrike Simone Frauke Reder, Tobias Kroll, Nora Wuerdemann, Jens Peter Klussmann, Claus Wittekindt

Erschienen in: European Archives of Oto-Rhino-Laryngology | Ausgabe 12/2018

Einloggen, um Zugang zu erhalten

Abstract

The 8th edition of the AJCC/UICC TNM-staging system for p16[HPV]-positive OPSCC manages to improve prediction of prognosis and will essentially influence choice of therapy in future. Nonetheless, adjustments of the current version are needed. The surrogate marker p16 alone is inadequate for HPV detection, the role of ECS in HPV-positive OPSCC is not fully understood, and the patient’s characteristics as well as molecular signatures and genetics have not been taken into consideration yet.
Literatur
1.
Zurück zum Zitat Ang KK, Harris J, Wheeler R et al (2010) Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 363(1):24–35CrossRef Ang KK, Harris J, Wheeler R et al (2010) Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 363(1):24–35CrossRef
2.
Zurück zum Zitat Huang SH, O’Sullivan B (2017) Overview of the 8th Edition TNM Classification for Head and Neck Cancer. Curr Treat Opt Oncol 18(7):40CrossRef Huang SH, O’Sullivan B (2017) Overview of the 8th Edition TNM Classification for Head and Neck Cancer. Curr Treat Opt Oncol 18(7):40CrossRef
3.
Zurück zum Zitat Wuerdemann N, Wittekindt C, Sharma SJ et al (2017) Risk factors for overall survival outcome in surgically treated human papillomavirus-negative and positive patients with oropharyngeal cancer. Oncol Res Treat 40(6):320–327CrossRef Wuerdemann N, Wittekindt C, Sharma SJ et al (2017) Risk factors for overall survival outcome in surgically treated human papillomavirus-negative and positive patients with oropharyngeal cancer. Oncol Res Treat 40(6):320–327CrossRef
4.
Zurück zum Zitat O’Sullivan B, Huang SH, Su J et al (2016) Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a multicentre cohort study. Lancet Oncol 17(4):440–451CrossRef O’Sullivan B, Huang SH, Su J et al (2016) Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a multicentre cohort study. Lancet Oncol 17(4):440–451CrossRef
5.
Zurück zum Zitat Klussmann JP, Gultekin E, Weissenborn SJ et al (2003) Expression of p16 protein identifies a distinct entity of tonsillar carcinomas associated with human papillomavirus. Am J Pathol 162(3):747–753CrossRef Klussmann JP, Gultekin E, Weissenborn SJ et al (2003) Expression of p16 protein identifies a distinct entity of tonsillar carcinomas associated with human papillomavirus. Am J Pathol 162(3):747–753CrossRef
6.
Zurück zum Zitat Prigge ES, Arbyn M, von Knebel Doeberitz M, Reuschenbach M (2017) Diagnostic accuracy of p16(INK4a) immunohistochemistry in oropharyngeal squamous cell carcinomas: a systematic review and meta-analysis. Int J Cancer 140(5):1186–1198CrossRef Prigge ES, Arbyn M, von Knebel Doeberitz M, Reuschenbach M (2017) Diagnostic accuracy of p16(INK4a) immunohistochemistry in oropharyngeal squamous cell carcinomas: a systematic review and meta-analysis. Int J Cancer 140(5):1186–1198CrossRef
7.
Zurück zum Zitat Rietbergen MM, Brakenhoff RH, Bloemena E et al (2013) Human papillomavirus detection and comorbidity: critical issues in selection of patients with oropharyngeal cancer for treatment de-escalation trials. Ann Oncol 24(11):2740–2745CrossRef Rietbergen MM, Brakenhoff RH, Bloemena E et al (2013) Human papillomavirus detection and comorbidity: critical issues in selection of patients with oropharyngeal cancer for treatment de-escalation trials. Ann Oncol 24(11):2740–2745CrossRef
8.
Zurück zum Zitat Smeets SJ, Hesselink AT, Speel EJ et al (2007) A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen. Int J Cancer 121(11):2465–2472CrossRef Smeets SJ, Hesselink AT, Speel EJ et al (2007) A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen. Int J Cancer 121(11):2465–2472CrossRef
9.
Zurück zum Zitat Porceddu SV, Milne R, Brown E et al (2017) Validation of the ICON-S staging for HPV-associated oropharyngeal carcinoma using a pre-defined treatment policy. Oral Oncol 66:81–86CrossRef Porceddu SV, Milne R, Brown E et al (2017) Validation of the ICON-S staging for HPV-associated oropharyngeal carcinoma using a pre-defined treatment policy. Oral Oncol 66:81–86CrossRef
10.
Zurück zum Zitat Huang SH, Xu W, Waldron J et al (2015) Refining American Joint Committee on Cancer/Union for International Cancer Control TNM stage and prognostic groups for human papillomavirus-related oropharyngeal carcinomas. J Clin Oncol 33(8):836–845CrossRef Huang SH, Xu W, Waldron J et al (2015) Refining American Joint Committee on Cancer/Union for International Cancer Control TNM stage and prognostic groups for human papillomavirus-related oropharyngeal carcinomas. J Clin Oncol 33(8):836–845CrossRef
11.
Zurück zum Zitat Malm IJ, Fan CJ, Yin LX et al (2017) Evaluation of proposed staging systems for human papillomavirus-related oropharyngeal squamous cell carcinoma. Cancer 123(10):1768–1777CrossRef Malm IJ, Fan CJ, Yin LX et al (2017) Evaluation of proposed staging systems for human papillomavirus-related oropharyngeal squamous cell carcinoma. Cancer 123(10):1768–1777CrossRef
12.
Zurück zum Zitat Zhan KY, Eskander A, Kang SY et al (2017) Appraisal of the AJCC 8th edition pathologic staging modifications for HPV-positive oropharyngeal cancer, a study of the National Cancer Data Base. Oral Oncol 73:152–159CrossRef Zhan KY, Eskander A, Kang SY et al (2017) Appraisal of the AJCC 8th edition pathologic staging modifications for HPV-positive oropharyngeal cancer, a study of the National Cancer Data Base. Oral Oncol 73:152–159CrossRef
13.
Zurück zum Zitat Coatesworth AP, MacLennan K (2002) Squamous cell carcinoma of the upper aerodigestive tract: the prevalence of microscopic extracapsular spread and soft tissue deposits in the clinically N0 neck. Head Neck 24(3):258–261CrossRef Coatesworth AP, MacLennan K (2002) Squamous cell carcinoma of the upper aerodigestive tract: the prevalence of microscopic extracapsular spread and soft tissue deposits in the clinically N0 neck. Head Neck 24(3):258–261CrossRef
14.
Zurück zum Zitat Greenberg JS, Fowler R, Gomez J et al (2003) Extent of extracapsular spread: a critical prognosticator in oral tongue cancer. Cancer 97(6):1464–1470CrossRef Greenberg JS, Fowler R, Gomez J et al (2003) Extent of extracapsular spread: a critical prognosticator in oral tongue cancer. Cancer 97(6):1464–1470CrossRef
15.
Zurück zum Zitat Lewis JS Jr, Carpenter DH, Thorstad WL, Zhang Q, Haughey BH (2011) Extracapsular extension is a poor predictor of disease recurrence in surgically treated oropharyngeal squamous cell carcinoma. Mod Pathol 24(11):1413–1420CrossRef Lewis JS Jr, Carpenter DH, Thorstad WL, Zhang Q, Haughey BH (2011) Extracapsular extension is a poor predictor of disease recurrence in surgically treated oropharyngeal squamous cell carcinoma. Mod Pathol 24(11):1413–1420CrossRef
16.
Zurück zum Zitat Sinha P, Kallogjeri D, Gay H et al (2015) High metastatic node number, not extracapsular spread or N-classification is a node-related prognosticator in transorally-resected, neck-dissected p16-positive oropharynx cancer. Oral Oncol 51(5):514–520CrossRef Sinha P, Kallogjeri D, Gay H et al (2015) High metastatic node number, not extracapsular spread or N-classification is a node-related prognosticator in transorally-resected, neck-dissected p16-positive oropharynx cancer. Oral Oncol 51(5):514–520CrossRef
17.
Zurück zum Zitat Haughey BH, Sinha P, Kallogjeri D et al (2016) Pathology-based staging for HPV-positive squamous carcinoma of the oropharynx. Oral Oncol 62:11–19CrossRef Haughey BH, Sinha P, Kallogjeri D et al (2016) Pathology-based staging for HPV-positive squamous carcinoma of the oropharynx. Oral Oncol 62:11–19CrossRef
18.
Zurück zum Zitat Klozar J, Koslabova E, Kratochvil V, Salakova M, Tachezy R (2013) Nodal status is not a prognostic factor in patients with HPV-positive oral/oropharyngeal tumors. J Surg Oncol 107(6):625–633CrossRef Klozar J, Koslabova E, Kratochvil V, Salakova M, Tachezy R (2013) Nodal status is not a prognostic factor in patients with HPV-positive oral/oropharyngeal tumors. J Surg Oncol 107(6):625–633CrossRef
19.
Zurück zum Zitat van den Brekel MW, Lodder WL, Stel HV, Bloemena E, Leemans CR, van der Waal I (2012) Observer variation in the histopathologic assessment of extranodal tumor spread in lymph node metastases in the neck. Head Neck 34(6):840–845CrossRef van den Brekel MW, Lodder WL, Stel HV, Bloemena E, Leemans CR, van der Waal I (2012) Observer variation in the histopathologic assessment of extranodal tumor spread in lymph node metastases in the neck. Head Neck 34(6):840–845CrossRef
20.
Zurück zum Zitat Maxwell JH, Ferris RL, Gooding W et al (2013) Extracapsular spread in head and neck carcinoma: impact of site and human papillomavirus status. Cancer 119(18):3302–3308CrossRef Maxwell JH, Ferris RL, Gooding W et al (2013) Extracapsular spread in head and neck carcinoma: impact of site and human papillomavirus status. Cancer 119(18):3302–3308CrossRef
21.
Zurück zum Zitat Wagner S, Wittekindt C, Sharma SJ et al (2017) Human papillomavirus association is the most important predictor for surgically treated patients with oropharyngeal cancer. Br J Cancer 116(12):1604–1611CrossRef Wagner S, Wittekindt C, Sharma SJ et al (2017) Human papillomavirus association is the most important predictor for surgically treated patients with oropharyngeal cancer. Br J Cancer 116(12):1604–1611CrossRef
22.
Zurück zum Zitat Brahmer JR, Tykodi SS, Chow LQ et al (2012) Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. N Engl J Med 366(26):2455–2465CrossRef Brahmer JR, Tykodi SS, Chow LQ et al (2012) Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. N Engl J Med 366(26):2455–2465CrossRef
23.
Zurück zum Zitat Garon EB, Rizvi NA, Hui R et al (2015) Pembrolizumab for the treatment of non-small-cell lung cancer. N Engl J Med 372(21):2018–2028CrossRef Garon EB, Rizvi NA, Hui R et al (2015) Pembrolizumab for the treatment of non-small-cell lung cancer. N Engl J Med 372(21):2018–2028CrossRef
Metadaten
Titel
The 8th edition AJCC/UICC TNM staging for p16-positive oropharyngeal carcinoma: is there space for improvement?
verfasst von
Shachi Jenny Sharma
Steffen Wagner
Henrike Simone Frauke Reder
Tobias Kroll
Nora Wuerdemann
Jens Peter Klussmann
Claus Wittekindt
Publikationsdatum
16.10.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
European Archives of Oto-Rhino-Laryngology / Ausgabe 12/2018
Print ISSN: 0937-4477
Elektronische ISSN: 1434-4726
DOI
https://doi.org/10.1007/s00405-018-5156-4

Weitere Artikel der Ausgabe 12/2018

European Archives of Oto-Rhino-Laryngology 12/2018 Zur Ausgabe

Nur selten Nachblutungen nach Abszesstonsillektomie

03.05.2024 Tonsillektomie Nachrichten

In einer Metaanalyse von 18 Studien war die Rate von Nachblutungen nach einer Abszesstonsillektomie mit weniger als 7% recht niedrig. Nur rund 2% der Behandelten mussten nachoperiert werden. Die Therapie scheint damit recht sicher zu sein.

Rezidivierender Peritonsillarabszess nach Oralsex

02.05.2024 Peritonsillarabszess Kasuistik

Die erotischen Dimensionen von Peritonsillarabszessen scheinen eng begrenzt zu sein. Das heißt aber nicht, solche Abszesse und Erotik hätten nichts miteinander gemein, wie ein Fallbericht verdeutlicht.

Endlich: Zi zeigt, mit welchen PVS Praxen zufrieden sind

IT für Ärzte Nachrichten

Darauf haben viele Praxen gewartet: Das Zi hat eine Liste von Praxisverwaltungssystemen veröffentlicht, die von Nutzern positiv bewertet werden. Eine gute Grundlage für wechselwillige Ärzte und Psychotherapeuten.

Kinder mit anhaltender Sinusitis profitieren häufig von Antibiotika

30.04.2024 Rhinitis und Sinusitis Nachrichten

Persistieren Sinusitisbeschwerden bei Kindern länger als zehn Tage, ist eine Antibiotikatherapie häufig gut wirksam: Ein Therapieversagen ist damit zu über 40% seltener zu beobachten als unter Placebo.

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.